BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carethers JM. Differentiating Lynch-like from Lynch syndrome. Gastroenterology 2014;146:602-4. [PMID: 24468183 DOI: 10.1053/j.gastro.2014.01.041] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 9.1] [Reference Citation Analysis]
Number Citing Articles
1 Kamburova ZB, Dimitrova PD, Dimitrova DS, Kovacheva KS, Popovska SL, Nikolova SE. Title of the manuscript: Lynch-like syndrome with germline WRN mutation in Bulgarian patient with synchronous endometrial and ovarian cancer.. [DOI: 10.21203/rs.3.rs-2430613/v1] [Reference Citation Analysis]
2 Nugroho PP, Ghozali SAS, Buchanan DD, Pisano MI, Reece JC. Risk of cancer in individuals with Lynch-like syndrome and their families: a systematic review. J Cancer Res Clin Oncol 2023;149:25-46. [PMID: 36251064 DOI: 10.1007/s00432-022-04397-0] [Reference Citation Analysis]
3 dos Santos W, de Andrade ES, Garcia FADO, Campacci N, Sábato CDS, Melendez ME, Reis RM, Galvão HDCR, Palmero EI. Whole-Exome Sequencing Identifies Pathogenic Germline Variants in Patients with Lynch-Like Syndrome. Cancers 2022;14:4233. [DOI: 10.3390/cancers14174233] [Reference Citation Analysis]
4 Jonnagadla S, Joseland SL, Saya S, den Elzen N, Isbister J, Winship IM, Buchanan DD. Heterogeneity in the psychosocial and behavioral responses associated with a diagnosis of suspected Lynch syndrome in women with endometrial cancer. Hered Cancer Clin Pract 2022;20:27. [PMID: 35840994 DOI: 10.1186/s13053-022-00233-1] [Reference Citation Analysis]
5 Martínez-Roca A, Giner-Calabuig M, Murcia O, Castillejo A, Soto JL, García-Heredia A, Jover R. Lynch-like Syndrome: Potential Mechanisms and Management. Cancers (Basel) 2022;14:1115. [PMID: 35267422 DOI: 10.3390/cancers14051115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Lagwinski NP, Petras RE. Gastrointestinal System. Gattuso's Differential Diagnosis in Surgical Pathology 2022. [DOI: 10.1016/b978-0-323-66165-2.00006-5] [Reference Citation Analysis]
7 Tatsuta K, Sakata M, Iwaizumi M, Shinmura K, Akai T, Kawamura T, Torii K, Morita Y, Kikuchi H, Hiramatsu Y, Fukazawa A, Kurachi K, Takeuchi H. Mismatch repair proteins immunohistochemical null phenotype in colon medullary carcinoma. Clin J Gastroenterol 2021. [PMID: 34279804 DOI: 10.1007/s12328-021-01484-6] [Reference Citation Analysis]
8 Haupt S, Gleim N, Ahadova A, Bläker H, Knebel Doeberitz M, Kloor M, Heuveline V. A computational model for investigating the evolution of colonic crypts during Lynch syndrome carcinogenesis. Comp Sys Onco 2021;1. [DOI: 10.1002/cso2.1020] [Reference Citation Analysis]
9 Son IT, Kim DW, Kim MH, Shin YK, Ku JL, Oh HK, Kang SB, Jeong SY, Park KJ. Comparison of oncologic outcomes between patients with Lynch syndrome and sporadic microsatellite instability-high colorectal cancer. Ann Surg Treat Res 2021;101:13-9. [PMID: 34235112 DOI: 10.4174/astr.2021.101.1.13] [Reference Citation Analysis]
10 Tomita N, Ishida H, Tanakaya K, Yamaguchi T, Kumamoto K, Tanaka T, Hinoi T, Miyakura Y, Hasegawa H, Takayama T, Ishikawa H, Nakajima T, Chino A, Shimodaira H, Hirasawa A, Nakayama Y, Sekine S, Tamura K, Akagi K, Kawasaki Y, Kobayashi H, Arai M, Itabashi M, Hashiguchi Y, Sugihara K; Japanese Society for Cancer of the Colon, Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer. Int J Clin Oncol 2021;26:1353-419. [PMID: 34185173 DOI: 10.1007/s10147-021-01881-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
11 Sahin IH, Klostergaard J. BRAF Mutations as Actionable Targets: A Paradigm Shift in the Management of Colorectal Cancer and Novel Avenues. JCO Oncol Pract 2021;:OP2100160. [PMID: 34077235 DOI: 10.1200/OP.21.00160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
12 Haupt S, Zeilmann A, Ahadova A, Bläker H, von Knebel Doeberitz M, Kloor M, Heuveline V. Mathematical modeling of multiple pathways in colorectal carcinogenesis using dynamical systems with Kronecker structure. PLoS Comput Biol 2021;17:e1008970. [PMID: 34003820 DOI: 10.1371/journal.pcbi.1008970] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Kagawa M, Kawakami S, Yamamoto A, Suzuki O, Eguchi H, Okazaki Y, Akagi K, Tamaru JI, Arai T, Yamaguchi T, Ishida H. Prevalence and clinicopathological/molecular characteristics of mismatch repair protein-deficient tumours among surgically treated patients with prostate cancer in a Japanese hospital-based population. Jpn J Clin Oncol 2021;51:639-45. [PMID: 33244609 DOI: 10.1093/jjco/hyaa207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Gallon R, Gawthorpe P, Phelps RL, Hayes C, Borthwick GM, Santibanez-Koref M, Jackson MS, Burn J. How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies. Cancers (Basel) 2021;13:406. [PMID: 33499123 DOI: 10.3390/cancers13030406] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
15 Yamamoto A, Yamaguchi T, Suzuki O, Ito T, Chika N, Kamae N, Tamaru JI, Nagai T, Seki H, Arai T, Tachikawa T, Akagi K, Eguchi H, Okazaki Y, Ishida H. Prevalence and molecular characteristics of DNA mismatch repair deficient endometrial cancer in a Japanese hospital-based population. Jpn J Clin Oncol 2021;51:60-9. [PMID: 32844218 DOI: 10.1093/jjco/hyaa142] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
16 Haupt S, Gleim N, Ahadova A, Bläker H, von Knebel Doeberitz M, Kloor M, Heuveline V. A computational model for investigating the evolution of colonic crypts during Lynch syndrome carcinogenesis.. [DOI: 10.1101/2020.12.29.424555] [Reference Citation Analysis]
17 Lefol C, Sohier E, Baudet C, Naïbo P, Ruano E, Grand-Masson C, Viari A, Wang Q. Acquired somatic MMR deficiency is a major cause of MSI tumor in patients suspected for "Lynch-like syndrome" including young patients. Eur J Hum Genet 2021;29:482-8. [PMID: 33279946 DOI: 10.1038/s41431-020-00778-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
18 Raeker MO, Carethers JM. Immunological Features with DNA Microsatellite Alterations in Patients with Colorectal Cancer. J Cancer Immunol (Wilmington) 2020;2:116-27. [PMID: 33000102 DOI: 10.33696/cancerimmunol.2.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
19 Munakata K, Koi M, Kitajima T, Tseng-Rogenski S, Uemura M, Matsuno H, Kawai K, Sekido Y, Mizushima T, Toiyama Y, Yamada T, Mano M, Mita E, Kusunoki M, Mori M, Carethers JM. Inflammation-Associated Microsatellite Alterations Caused by MSH3 Dysfunction Are Prevalent in Ulcerative Colitis and Increase With Neoplastic Advancement. Clin Transl Gastroenterol 2019;10:e00105. [PMID: 31789935 DOI: 10.14309/ctg.0000000000000105] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
20 Golubicki M, Bonjoch L, Acuña-Ochoa JG, Díaz-Gay M, Muñoz J, Cuatrecasas M, Ocaña T, Iseas S, Mendez G, Cisterna D, Schubert SA, Nielsen M, van Wezel T, Goldberg Y, Pikarsky E, Robbio J, Roca E, Castells A, Balaguer F, Antelo M, Castellví-Bel S. Germline biallelic Mcm8 variants are associated with early-onset Lynch-like syndrome. JCI Insight 2020;5:140698. [PMID: 32841224 DOI: 10.1172/jci.insight.140698] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
21 Xu Y, Huang Z, Li C, Zhu C, Zhang Y, Guo T, Liu F, Xu Y. Comparison of Molecular, Clinicopathological, and Pedigree Differences Between Lynch-Like and Lynch Syndromes. Front Genet 2020;11:991. [PMID: 32973888 DOI: 10.3389/fgene.2020.00991] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
22 Haupt S, Zeilmann A, Ahadova A, von Knebel Doeberitz M, Kloor M, Heuveline V. Mathematical Modeling of Multiple Pathways in Colorectal Carcinogenesis using Dynamical Systems with Kronecker Structure.. [DOI: 10.1101/2020.08.14.250175] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Tseng-Rogenski SS, Munakata K, Choi DY, Martin PK, Mehta S, Koi M, Zheng W, Zhang Y, Carethers JM. The Human DNA Mismatch Repair Protein MSH3 Contains Nuclear Localization and Export Signals That Enable Nuclear-Cytosolic Shuttling in Response to Inflammation. Mol Cell Biol 2020;40:e00029-20. [PMID: 32284349 DOI: 10.1128/MCB.00029-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
24 Vos JR, Fakkert IE, Spruijt L, Willems RW, Langenveld S, Mensenkamp AR, Leter EM, Nagtegaal ID, Ligtenberg MJL, Hoogerbrugge N; FINAL Group. Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome. Int J Cancer 2020;147:2150-8. [PMID: 32510614 DOI: 10.1002/ijc.33117] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
25 Wong S, Hui P, Buza N. Frequent loss of mutation-specific mismatch repair protein expression in nonneoplastic endometrium of Lynch syndrome patients. Mod Pathol 2020;33:1172-81. [PMID: 31932681 DOI: 10.1038/s41379-020-0455-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
26 Raskov H, Søby JH, Troelsen J, Bojesen RD, Gögenur I. Driver Gene Mutations and Epigenetics in Colorectal Cancer. Ann Surg 2020;271:75-85. [PMID: 31188207 DOI: 10.1097/SLA.0000000000003393] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 12.3] [Reference Citation Analysis]
27 Carethers JM. High predictability for identifying Lynch syndrome via microsatellite instability testing or immunohistochemistry in all Lynch-associated tumor types. Transl Cancer Res 2019;8:S559-63. [PMID: 32266124 DOI: 10.21037/tcr.2019.08.10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
28 Desouza B, Georgiou D. Advances in Hereditary Colorectal Cancer: Opportunities and Challenges for Clinical Translation. Curr Genet Med Rep 2020;8:47-60. [DOI: 10.1007/s40142-020-00183-x] [Reference Citation Analysis]
29 Monahan KJ, Bradshaw N, Dolwani S, Desouza B, Dunlop MG, East JE, Ilyas M, Kaur A, Lalloo F, Latchford A, Rutter MD, Tomlinson I, Thomas HJW, Hill J; Hereditary CRC guidelines eDelphi consensus group. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG). Gut 2020;69:411-44. [PMID: 31780574 DOI: 10.1136/gutjnl-2019-319915] [Cited by in Crossref: 160] [Cited by in F6Publishing: 156] [Article Influence: 53.3] [Reference Citation Analysis]
30 Taggart MW, Foo WC, Lee SM. Tumors of the Gastrointestinal System Including the Pancreas. Oncological Surgical Pathology 2020. [DOI: 10.1007/978-3-319-96681-6_12] [Reference Citation Analysis]
31 Arora N. Hereditary Endometrial Cancers. Recent Advances in Endometrial Cancer 2020. [DOI: 10.1007/978-981-15-5317-2_4] [Reference Citation Analysis]
32 Arnold AM, Morak M, Benet-Pagès A, Laner A, Frishman D, Holinski-Feder E. Targeted deep-intronic sequencing in a cohort of unexplained cases of suspected Lynch syndrome. Eur J Hum Genet 2020;28:597-608. [PMID: 31822864 DOI: 10.1038/s41431-019-0536-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
33 Evrard C, Tachon G, Randrian V, Karayan-Tapon L, Tougeron D. Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer. Cancers (Basel) 2019;11:E1567. [PMID: 31618962 DOI: 10.3390/cancers11101567] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 19.5] [Reference Citation Analysis]
34 Xavier A, Olsen MF, Lavik LA, Johansen J, Singh AK, Sjursen W, Scott RJ, Talseth-Palmer BA. Comprehensive mismatch repair gene panel identifies variants in patients with Lynch-like syndrome. Mol Genet Genomic Med 2019;7:e850. [PMID: 31297992 DOI: 10.1002/mgg3.850] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
35 Sillo TO, Beggs AD, Morton DG, Middleton G. Mechanisms of immunogenicity in colorectal cancer. Br J Surg 2019;106:1283-97. [PMID: 31216061 DOI: 10.1002/bjs.11204] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
36 Rau TT, Dawson H, Hartmann A, Rüschoff J. [Hereditary colorectal cancer : An update on genetics and entities in terms of differential diagnosis]. Pathologe 2017;38:156-63. [PMID: 28474162 DOI: 10.1007/s00292-017-0294-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
37 Wadee R, Grayson W. A potpourri of pathogenetic pathways in endometrial carcinoma with a focus on Lynch Syndrome. Ann Diagn Pathol 2019;39:92-104. [PMID: 30798077 DOI: 10.1016/j.anndiagpath.2019.02.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
38 Antelo M, Golubicki M, Roca E, Mendez G, Carballido M, Iseas S, Cuatrecasas M, Moreira L, Sanchez A, Carballal S, Castells A, Boland CR, Goel A, Balaguer F. Lynch-like syndrome is as frequent as Lynch syndrome in early-onset nonfamilial nonpolyposis colorectal cancer. Int J Cancer 2019;145:705-13. [PMID: 30693488 DOI: 10.1002/ijc.32160] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
39 Porkka N, Lahtinen L, Ahtiainen M, Böhm JP, Kuopio T, Eldfors S, Mecklin JP, Seppälä TT, Peltomäki P. Epidemiological, clinical and molecular characterization of Lynch-like syndrome: A population-based study. Int J Cancer 2019;145:87-98. [PMID: 30575961 DOI: 10.1002/ijc.32085] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
40 Kalady MF, Boland CR, Church JM. Inherited Colorectal Cancer and the Genetics of Colorectal Cancer. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. Elsevier; 2019. pp. 1959-80. [DOI: 10.1016/b978-0-323-40232-3.00165-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Wong H, Christie M, Gately L, Tie J, Lee B, Semira C, Lok SW, Wong R, Gibbs P. Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond. Future Oncology 2018;14:2725-39. [DOI: 10.2217/fon-2018-0319] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
42 Salman P, Panay S, Fernández R, Mahave M, Soza-Ried C. Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer. Onco Targets Ther 2018;11:7295-300. [PMID: 30425520 DOI: 10.2147/OTT.S167645] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
43 Goshayeshi L, Ghaffarzadegan K, Khooei A, Esmaeilzadeh A, Rahmani Khorram M, Mosannen Mozaffari H, Kiani B, Hoseini B. Prevalence and clinicopathological characteristics of mismatch repair-deficient colorectal carcinoma in early onset cases as compared with late-onset cases: a retrospective cross-sectional study in Northeastern Iran. BMJ Open 2018;8:e023102. [PMID: 30166308 DOI: 10.1136/bmjopen-2018-023102] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
44 Wang A, McCracken J, Li Y, Xu L. The practice of universal screening for Lynch syndrome in newly diagnosed endometrial carcinoma. Health Sci Rep 2018;1:e43. [PMID: 30623082 DOI: 10.1002/hsr2.43] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
45 Minamiguchi K, Takahama J, Uchiyama T, Taiji R, Saito N, Okada H, Marugami N, Tanase Y, Kawaguchi R, Ohbayashi C, Kobayashi H, Hirai T, Kichikawa K. Uterine endometrial carcinoma with DNA mismatch repair deficiency: magnetic resonance imaging findings and clinical features. Jpn J Radiol 2018;36:429-36. [DOI: 10.1007/s11604-018-0741-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
46 Chen E, Xu X, Liu T. Hereditary Nonpolyposis Colorectal Cancer and Cancer Syndromes: Recent Basic and Clinical Discoveries. J Oncol 2018;2018:3979135. [PMID: 29849630 DOI: 10.1155/2018/3979135] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
47 Hussein YR, Soslow RA. Molecular insights into the classification of high-grade endometrial carcinoma. Pathology 2018;50:151-61. [PMID: 29246451 DOI: 10.1016/j.pathol.2017.09.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
48 Dillon JL, Gonzalez JL, DeMars L, Bloch KJ, Tafe LJ. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Hum Pathol 2017;70:121-8. [PMID: 29107668 DOI: 10.1016/j.humpath.2017.10.022] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 9.5] [Reference Citation Analysis]
49 Katz LH, Advani S, Burton-Chase AM, Fellman B, Polivka KM, Yuan Y, Lynch PM, Peterson SK. Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency. Fam Cancer 2017;16:231-7. [PMID: 27832499 DOI: 10.1007/s10689-016-9947-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
50 Zeinalian M, Hadian M, Hashemzadeh-Chaleshtori M, Salehi R, Emami MH. Familial Colorectal Cancer Type X in Central Iran: A New Clinicopathologic Description. Int J Hematol Oncol Stem Cell Res 2017;11:240-5. [PMID: 28989591] [Reference Citation Analysis]
51 Abu Freha N, Leibovici Weissman Y, Fich A, Barnes Kedar I, Halpern M, Sztarkier I, Behar DM, Arbib Sneh O, Vilkin A, Baris HN, Gingold R, Lejbkowicz F, Niv Y, Goldberg Y, Levi Z. Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel. Familial Cancer 2018;17:79-86. [DOI: 10.1007/s10689-017-0009-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
52 Valle L. Recent Discoveries in the Genetics of Familial Colorectal Cancer and Polyposis. Clin Gastroenterol Hepatol 2017;15:809-19. [PMID: 27712984 DOI: 10.1016/j.cgh.2016.09.148] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 9.2] [Reference Citation Analysis]
53 Carethers JM. Microsatellite Instability Pathway and EMAST in Colorectal Cancer. Curr Colorectal Cancer Rep. 2017;13:73-80. [PMID: 28367107 DOI: 10.1007/s11888-017-0352-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
54 Liccardo R, De Rosa M, Izzo P, Duraturo F. Novel Implications in Molecular Diagnosis of Lynch Syndrome. Gastroenterol Res Pract 2017;2017:2595098. [PMID: 28250766 DOI: 10.1155/2017/2595098] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
55 Shawki S, Kalady MF. Recent advances in understanding Lynch syndrome. F1000Res 2016;5:2889. [PMID: 28105321 DOI: 10.12688/f1000research.9654.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
56 Koelzer VH, Steuer K, Gross UC, Zimmermann D, Paasinen-Sohns A, Mertz KD, Cathomas G. Colorectal Choriocarcinoma in a Patient with Probable Lynch Syndrome. Front Oncol 2016;6:252. [PMID: 27965933 DOI: 10.3389/fonc.2016.00252] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
57 Cohen SA, Turner EH, Beightol MB, Jacobson A, Gooley TA, Salipante SJ, Haraldsdottir S, Smith C, Scroggins S, Tait JF, Grady WM, Lin EH, Cohn DE, Goodfellow PJ, Arnold MW, de la Chapelle A, Pearlman R, Hampel H, Pritchard CC. Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes. Gastroenterology 2016;151:440-447.e1. [PMID: 27302833 DOI: 10.1053/j.gastro.2016.06.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
58 Carethers JM. Neoplasia. Practical Gastroenterology and Hepatology Board Review Toolkit 2016. [DOI: 10.1002/9781119127437.ch31] [Reference Citation Analysis]
59 de Rosa N, Rodriguez-Bigas MA, Chang GJ, Veerapong J, Borras E, Krishnan S, Bednarski B, Messick CA, Skibber JM, Feig BW. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. J Clin Oncol. 2016;34:3039-3046. [PMID: 27432916 DOI: 10.1200/JCO.2016.66.6826] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 8.9] [Reference Citation Analysis]
60 Hahn MM, de Voer RM, Hoogerbrugge N, Ligtenberg MJ, Kuiper RP, van Kessel AG. The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery. Cell Oncol (Dordr) 2016;39:491-510. [PMID: 27279102 DOI: 10.1007/s13402-016-0284-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
61 Mills AM, Sloan EA, Thomas M, Modesitt SC, Stoler MH, Atkins KA, Moskaluk CA. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry. Am J Surg Pathol 2016;40:155-65. [PMID: 26523542 DOI: 10.1097/PAS.0000000000000544] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 6.7] [Reference Citation Analysis]
62 Djordjevic B, Broaddus RR. Laboratory Assays in Evaluation of Lynch Syndrome in Patients with Endometrial Carcinoma. Surg Pathol Clin 2016;9:289-99. [PMID: 27241109 DOI: 10.1016/j.path.2016.01.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
63 Peña-Diaz J, Rasmussen LJ. Approaches to diagnose DNA mismatch repair gene defects in cancer. DNA Repair (Amst) 2016;38:147-54. [PMID: 26708048 DOI: 10.1016/j.dnarep.2015.11.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
64 Carethers JM, Jung BH. Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer. Gastroenterology 2015;149:1177-1190.e3. [PMID: 26216840 DOI: 10.1053/j.gastro.2015.06.047] [Cited by in Crossref: 254] [Cited by in F6Publishing: 281] [Article Influence: 31.8] [Reference Citation Analysis]
65 Katz LH, Burton-Chase AM, Advani S, Fellman B, Polivka KM, Yuan Y, Lynch PM, Peterson SK. Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome. Clin Genet 2016;89:392-8. [PMID: 26272410 DOI: 10.1111/cge.12653] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
66 Carethers JM, Stoffel EM. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer. World J Gastroenterol 2015; 21(31): 9253-9261 [PMID: 26309352 DOI: 10.3748/wjg.v21.i31.9253] [Cited by in CrossRef: 122] [Cited by in F6Publishing: 129] [Article Influence: 15.3] [Reference Citation Analysis]
67 Lynch PM. The Case for Universal Testing of Colorectal Tumors for Microsatellite Instability: A Coming Mismatch Between Clinical and Laboratory Testing. Dig Dis Sci 2015;60:2225-7. [PMID: 26123836 DOI: 10.1007/s10620-015-3739-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Lynch HT, Drescher K, Knezetic J, Lanspa S. Genetics, biomarkers, hereditary cancer syndrome diagnosis, heterogeneity and treatment: a review. Curr Treat Options Oncol. 2014;15:429-442. [PMID: 24827900 DOI: 10.1007/s11864-014-0293-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
69 Hamaya Y, Guarinos C, Tseng-Rogenski SS, Iwaizumi M, Das R, Jover R, Castells A, Llor X, Andreu M, Carethers JM. Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer. PLoS One. 2015;10:e0127591. [PMID: 25996601 DOI: 10.1371/journal.pone.0127591] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
70 Carethers JM, Koi M, Tseng-Rogenski SS. EMAST is a Form of Microsatellite Instability That is Initiated by Inflammation and Modulates Colorectal Cancer Progression. Genes (Basel). 2015;6:185-205. [PMID: 25836926 DOI: 10.3390/genes6020185] [Cited by in Crossref: 67] [Cited by in F6Publishing: 74] [Article Influence: 8.4] [Reference Citation Analysis]
71 Dulal S, Keku TO. Gut microbiome and colorectal adenomas. Cancer J 2014;20:225-31. [PMID: 24855012 DOI: 10.1097/PPO.0000000000000050] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 9.4] [Reference Citation Analysis]
72 Staffa L, Echterdiek F, Nelius N, Benner A, Werft W, Lahrmann B, Grabe N, Schneider M, Tariverdian M, von Knebel Doeberitz M. Mismatch repair-deficient crypt foci in Lynch syndrome--molecular alterations and association with clinical parameters. PLoS One. 2015;10:e0121980. [PMID: 25816162 DOI: 10.1371/journal.pone.0121980] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
73 Carethers JM. Screening for colorectal cancer in African Americans: determinants and rationale for an earlier age to commence screening. Dig Dis Sci 2015;60:711-21. [PMID: 25540085 DOI: 10.1007/s10620-014-3443-5] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 7.9] [Reference Citation Analysis]
74 Tseng-Rogenski SS, Hamaya Y, Choi DY, Carethers JM. Interleukin 6 alters localization of hMSH3, leading to DNA mismatch repair defects in colorectal cancer cells. Gastroenterology 2015;148:579-89. [PMID: 25461668 DOI: 10.1053/j.gastro.2014.11.027] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]
75 Prasad MA, Jung B. Microsatellite Instability and Intestinal Tumorigenesis. Intestinal Tumorigenesis 2015. [DOI: 10.1007/978-3-319-19986-3_2] [Reference Citation Analysis]
76 Raskov H, Pommergaard HC, Burcharth J, Rosenberg J. Colorectal carcinogenesis-update and perspectives. World J Gastroenterol 2014; 20(48): 18151-18164 [PMID: 25561783 DOI: 10.3748/wjg.v20.i48.18151] [Cited by in CrossRef: 104] [Cited by in F6Publishing: 117] [Article Influence: 11.6] [Reference Citation Analysis]
77 Haraldsdottir S, Hampel H, Tomsic J, Frankel WL, Pearlman R, de la Chapelle A, Pritchard CC. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. Gastroenterology 2014;147:1308-1316.e1. [PMID: 25194673 DOI: 10.1053/j.gastro.2014.08.041] [Cited by in Crossref: 266] [Cited by in F6Publishing: 287] [Article Influence: 29.6] [Reference Citation Analysis]
78 Gould-Suarez M, El-Serag HB, Musher B, Franco LM, Chen GJ. Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome. Dig Dis Sci 2014;59:2913-26. [PMID: 24957400 DOI: 10.1007/s10620-014-3248-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
79 Konstantinopoulos PA, Matulonis UA. POLE mutations as an alternative pathway for microsatellite instability in endometrial cancer: implications for Lynch syndrome testing. Cancer 2015;121:331-4. [PMID: 25224324 DOI: 10.1002/cncr.29057] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
80 Kang SY, Park CK, Chang DK, Kim JW, Son HJ, Cho YB, Yun SH, Kim HC, Kwon M, Kim K. Lynch-like syndrome: Characterization and comparison with EPCAM deletion carriers: Pathway of Lynch-like Syndrome. Int J Cancer 2015;136:1568-78. [DOI: 10.1002/ijc.29133] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
81 Ferguson SE, Aronson M, Pollett A, Eiriksson LR, Oza AM, Gallinger S, Lerner-Ellis J, Alvandi Z, Bernardini MQ, MacKay HJ, Mojtahedi G, Tone AA, Massey C, Clarke BA. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing. Cancer 2014;120:3932-9. [PMID: 25081409 DOI: 10.1002/cncr.28933] [Cited by in Crossref: 89] [Cited by in F6Publishing: 94] [Article Influence: 9.9] [Reference Citation Analysis]
82 Carethers JM, Murali B, Yang B, Doctolero RT, Tajima A, Basa R, Smith EJ, Lee M, Janke R, Ngo T, Tejada R, Ji M, Kinseth M, Cabrera BL, Miyai K, Keku TO, Martin CF, Galanko JA, Sandler RS, McGuire KL. Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancer. PLoS One 2014;9:e100461. [PMID: 24956473 DOI: 10.1371/journal.pone.0100461] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 6.1] [Reference Citation Analysis]
83 Ren C, Liu Y, Wang Y, Tang Y, Wei Y, Liu C, Zhang H. Identification of novel Lynch syndrome mutations in Chinese patients with endometriod endometrial cancer. Cancer Biol Med 2020;17:458-67. [PMID: 32587781 DOI: 10.20892/j.issn.2095-3941.2019.0295] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]